
Airsupra 90mcg/80mcg 120 Inhalations
103.10
- Brand: Airsupra
- Product Form: AIRSUPRA
Home delivery within 2 hours
Home delivery within 2 hours
Product Description
- AIRSUPRA is a pressurized inhalation suspension combining 90 mcg of salbutamol (a short-acting beta2-agonist) and 80 mcg of budesonide (an inhaled corticosteroid) per actuation.
- It is indicated for the as-needed treatment or prevention of bronchoconstriction and the reduction of exacerbation risk in asthma patients aged 18 and older.
- Clinical studies, such as MANDALA and DENALI, demonstrate that the combination significantly reduces severe asthma exacerbations and improves lung function compared to monotherapies.
How To Use
- For relief of bronchoconstriction, administer 2 actuations (delivering a total of 180 mcg salbutamol and 160 mcg budesonide) as needed.
- For prevention of exercise-induced bronchoconstriction, administer 2 actuations 15 to 30 minutes prior to physical activity.
- Do not exceed a maximum of 6 doses (12 inhalations) within a 24-hour period.
- No dosage adjustment is required for elderly patients; however, safety and effectiveness have not been established for adolescents aged 12 to 17.
Warnings And Precautions
- Contraindicated in patients with known hypersensitivity to salbutamol, budesonide, or any of the formulation excipients.
- Patients should seek immediate medical advice if they experience a paradoxical bronchospasm or if increased bronchodilator use is required, as this indicates worsening asthma control.
- Use with caution in patients with cardiovascular disorders (e.g., severe heart disease, hypertension), thyrotoxicosis, or hypokalaemia.
- Usage during pregnancy or breastfeeding should only be considered if the expected benefit to the mother outweighs the potential risks to the fetus or infant.
- Avoid concomitant use with non-selective beta-blockers and exercise caution with strong CYP3A4 inhibitors (e.g., ketoconazole).
Ingredients
- Active Ingredients: Salbutamol (90 mcg per actuation) and Budesonide (80 mcg per actuation).
- Propellant: Norflurane (HFA-134a).
- Excipients: 1,2-Distearoyl-sn-glycero-3-phosphocholine (DSPC) and Calcium Chloride.
Product Details:
- Brand: Airsupra
- Product Form: AIRSUPRA

Genuine brands

Temperature Controlled

Secure Payment
- Brand: Airsupra
- Product Form: AIRSUPRA

Genuine brands

Temperature Controlled

Secure Payment
About Product
Product Description
- AIRSUPRA is a pressurized inhalation suspension combining 90 mcg of salbutamol (a short-acting beta2-agonist) and 80 mcg of budesonide (an inhaled corticosteroid) per actuation.
- It is indicated for the as-needed treatment or prevention of bronchoconstriction and the reduction of exacerbation risk in asthma patients aged 18 and older.
- Clinical studies, such as MANDALA and DENALI, demonstrate that the combination significantly reduces severe asthma exacerbations and improves lung function compared to monotherapies.
How To Use
- For relief of bronchoconstriction, administer 2 actuations (delivering a total of 180 mcg salbutamol and 160 mcg budesonide) as needed.
- For prevention of exercise-induced bronchoconstriction, administer 2 actuations 15 to 30 minutes prior to physical activity.
- Do not exceed a maximum of 6 doses (12 inhalations) within a 24-hour period.
- No dosage adjustment is required for elderly patients; however, safety and effectiveness have not been established for adolescents aged 12 to 17.
Warnings And Precautions
- Contraindicated in patients with known hypersensitivity to salbutamol, budesonide, or any of the formulation excipients.
- Patients should seek immediate medical advice if they experience a paradoxical bronchospasm or if increased bronchodilator use is required, as this indicates worsening asthma control.
- Use with caution in patients with cardiovascular disorders (e.g., severe heart disease, hypertension), thyrotoxicosis, or hypokalaemia.
- Usage during pregnancy or breastfeeding should only be considered if the expected benefit to the mother outweighs the potential risks to the fetus or infant.
- Avoid concomitant use with non-selective beta-blockers and exercise caution with strong CYP3A4 inhibitors (e.g., ketoconazole).
Ingredients
- Active Ingredients: Salbutamol (90 mcg per actuation) and Budesonide (80 mcg per actuation).
- Propellant: Norflurane (HFA-134a).
- Excipients: 1,2-Distearoyl-sn-glycero-3-phosphocholine (DSPC) and Calcium Chloride.
Product Details:
- Brand: Airsupra
- Product Form: AIRSUPRA